Cancer Drugs News
Most Popular Cancer Drugs Story
FDA's Pazdur in the middle of intense debate
The argument over the FDA's role in regulating cancer therapies often comes down to one man: Dr. Richard Pazdur, a veteran oncologist and chief of the agency's oncology office. Patient groups and... Read more...
Latest Headlines
- July 28, 2009
- April 28, 2009
- November 14, 2008
- October 8, 2008
- September 23, 2008
- September 2, 2008
- March 18, 2008
- February 26, 2008
- January 10, 2007
- November 29, 2006
- November 1, 2006
- July 24, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
